🟢 Cue Biopharma is trading 5.65% up in pre-market with no confirmed catalyst

Cue Biopharma is trading at $26.00, up 5.65%, in pre-market, with the reason for the move unconfirmed.

• Cue Biopharma closed at $24.61 on October 12, following an 11.03% decline that session; those figures are from the provided price context.
• No confirmed new company announcement explains the October 13 pre-market rise. The B. Riley Buy initiation in search results dates to September, not overnight.
• Broader market signals are mixed and do not clearly explain the stock’s upward move.